| Tag | Content |
|---|
EnhancerAtlas ID | HS034-18806 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr20:46174960-46175820 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| E2F6 | MA0471.1 | chr20:46175514-46175525 | TCTTCCCGCCC | - | 6.14 | | GRHL1 | MA0647.1 | chr20:46175159-46175171 | TAAACCGGTTTG | + | 6.14 | | GRHL1 | MA0647.1 | chr20:46175159-46175171 | TAAACCGGTTTG | - | 6.32 | | TFCP2 | MA0145.3 | chr20:46175160-46175170 | AAACCGGTTT | + | 6.02 | | TFCP2 | MA0145.3 | chr20:46175160-46175170 | AAACCGGTTT | - | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_10904 | chr20:46158101-46176240 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH20I047545 | chr20 | 46173904 | 46175810 |
|
Enhancer Sequence | CTTAAAAACC TTGACTACTC TTTTATCTCC TTGCTATTTT TAAGATATAT GTAGTGTCTG 60
GCCACATCTC AGTAATTCCA TTGAACCAAC ATTTTCTGTG AGTTATTGTA ATAACATCCT 120
AATAAGTCTT CCTGCATTTT ACTCTTGTTT CCTTGTATCC TGTTAGTAAC GTAACAGCTG 180
GAGGGATCTT TTACAATCCT AAACCGGTTT GTCATTCCTC TCTTCTAGAC TATGTAGAGG 240
TTTCTTATTT CACCCGGAGT AGAAATGAAA GTTCTTACTT TGTTTCAATG AGACTCTGTG 300
ACTTGCCTCT GTTTTTTTTT TTTTTTTTTT TTAAGACCGA ATTTCCCTCT TGTTGCCTAG 360
GCTGAAGTGC AGTGGCGCAG TCTTGGCTCA CTGCAACCTC CGCCTCCCGC ATTCAAGTGA 420
TTCTTCTGCC TCAGCCTCTC GAGTTGCTGG GATTACAGGC ATGTGCTACC ACGCCCAGCT 480
AATTTTGTAT TTTTAGTAGA GATGGGGTTT CTCCATGTTG GTCAGGCTGG TCTTGAACTC 540
CCTAACTCAG GTGATCTTCC CGCCCTGGCC TCCCAAAGTG CTGAGGTTAC AGGCATGAGC 600
CACCGCTACC GGCCTGCCTC TGTTACATCT CTGATCTCAC CTATCATTCC TGTCTTCCTT 660
GTTCATTCTT GATCCAGTAC CGTTCTTCAT CCAGTGCAGG CACATTCTTG CCTTTGGGTA 720
TGCCCTTTCT TGGAATGTTT CTGTCATATG TCTGATTAAG TTCCTCATCT CTTTAAAGTC 780
TCAATTCTTA CACTCTTAAT GAGGCCCACC CTTACCACCC TATTTAATAC CGGAACCTCT 840
GACCTTATAG CACTAATGCT 860
|
